IEX •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 08/24/2026 15:59
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeIEX
Market Capitalization170.69 mln
Float94.22 mln
Earnings Date12/22/2026
EPS
0.43
Marginal
P / E
2.90
Deeply undervalued
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-2.39
Borderline
Relative Strength
96
/ 100
Top performer
Debt / Equity
0.02
Debt-free
Business Description
Organigram Global Inc. is a Canadian cannabis company that grows, produces, and sells a wide range of cannabis products for both medical patients and adult recreational users. Its portfolio spans dried flower, pre-rolls, vapes, edibles, beverages, and concentrates, marketed under more than a dozen well-known brands. The company also supplies cannabis cuttings and dried flower to other licensed producers and distributes its products through retail stores, wholesale partners, and online channels across Canada. Formerly known as Organigram Holdings Inc., the company rebranded in March 2025 and is based in Toronto.
